Pediatric Blood and Marrow Transplant Consortium

PBMTC Publications List

See a complete list of PBMTC publications here

Recent Peer-Reviewed Publications

1. Safety, efficacy, and pharmacokinetics of intravenous busulfan in children undergoing allogeneic hematopoietic stem cell transplantation. Wall DA, Chan KW, Nieder ML, Hayashi RJ, Yeager AM, Kadota R, Przepiorka D, Mezzi K, Kletzel M; Pediatric Blood, Marrow Transplant Consortium. Pediatr Blood Cancer. 2010 Feb; 54(2):291-8.

2. Impact of Conditioning Regimen in Allogeneic Hematopoietic Stem Cell Transplantation for Children with Acute Myelogenous Leukemia beyond First Complete Remission: A Pediatric Blood and Marrow Transplant Consortium (PBMTC) Study. India Y. Sisler, Elizabeth Koehler, Tatsuki Koyama, Jennifer A. Domm, Robin Ryan, John E. Levine, Michael A. Pulsipher, Paul R. Haut, Kirk R. Schultz, Douglas S. Taylor, Haydar A. Frangoul. Biology of Blood and Marrow Transplantation. December 2009 (Vol. 15, Issue 12, Pages 1620-1627)

3. Evaluation of pentostatin in corticosteroid-refractory chronic graft-versus-host disease in children: a Pediatric Blood and Marrow Transplant Consortium study. Jacobsohn DA. Gilman AL. Rademaker A. Browning B. Grimley M. Lehmann L. Nemecek ER. Thormann K. Schultz KR. Vogelsang GB. Blood. 114(20):4354-60, 2009 Nov 12.

4. Reduced-intensity allogeneic transplantation in pediatric patients ineligible for myeloablative therapy: results of the Pediatric Blood and Marrow Transplant Consortium Study ONC0313. Pulsipher MA. Boucher KM. Wall D. Frangoul H. Duval M. Goyal RK. Shaw PJ. Haight AE. Grimley M. Grupp SA. Kletzel M. Kadota R. Blood. 114(7):1429-36, 2009 Aug 13.

5. Unrelated umbilical cord blood transplantation in children with immune deficiency: results of a multicenter study. Frangoul H, Wang L, Harrell FE Jr, Manes B, Calder C, Domm J. Bone Marrow Transplant. 2009 Jun 22.

6. A pilot study of addition of amifostine to melphalan, carboplatin, etoposide, and cyclophosphamide with autologous hematopoietic stem cell transplantation in pediatric solid tumors-A pediatric blood and marrow transplant consortium study. Ozkaynak MF. Sahdev I. Gross TG. Levine JE. Cheerva AC. Richards MK. Rozans MK. Shaw PJ. Kadota RP. Journal of Pediatric Hematology/Oncology. 30(3):204-9, 2008 Mar.

7. A prospective study of G-CSF primed bone marrow as a stem-cell source for allogeneic bone marrow transplantation in children: a Pediatric Blood and Marrow Transplant Consortium (PBMTC) study. Frangoul H. Nemecek ER. Billheimer D. Pulsipher MA. Khan S. Woolfrey A. Manes B. Cole C. Walters MC. Ayas M. Ravindranath Y. Levine JE. Grupp SA. Blood. 110(13):4584-7, 2007 Dec 15.

Recent Abstract Presentations

1. Multi-Institutional Phase II Study of Pentostatin for the Treatment of Refractory Chronic GVHD (cGVHD) in Children: A Pediatric Blood and Marrow Transplant Consortium (PBMTC) Study. D.A. Jacobsohn, B. Browning, A. Gilman, L. Lehmann, E. Nemecek, K. Thormann, G.B. Vogelsang. Biology of Blood and Marrow Transplantation February 2008 (Vol. 14, Issue 2, Supplement, Page 25)

2. Fungal Infections: A Survey of Pediatric Survey of Pediatric Blood & Marrow Transplant Consortium Institutions. V.L. Fisher, E.A. Olson. Biology of Blood and Marrow Transplantation February 2008 (Vol. 14, Issue 2, Supplement, Pages 84-85)

3. Viral Infections: A Survey of Pediatric Blood and Marrow Transplant Consortium Institutions. E.A. Olson, V. Fisher. Biology of Blood and Marrow Transplantation February 2008 (Vol. 14, Issue 2, Supplement, Page 86)

4. Impact of Conditioning Regimen in Allogeneic Hematopoietic Stem Cell Transplant for Children with AML beyond the First Complete Remission: Total Body Irradiation Versus Busulfan- a Pediatric Blood and Marrow Transplant Consortium (PBMTC) Study. Sisler I, Domm J, Ryan R, Levine JE, Pulsipher M, Haut P, Schultz KR, Koyama T, Koehler E, Taylor D, Frangoul H. ASH 2008 Abstract (Poster)

5. Low rates of toxicity and long-term responses after bu/flu/ATG RIC allogeneic transplantation in very high risk pediatric patients ineligible for myelablative therapy: A Pediatric Blood and Marrow Transplant Consortium Study. M.A. Pulsipher, R. Goyal, H. Frangoul, P. Shaw, A. Haight, R. Kadota, D. Wall, S. Grupp, M. Kletzel. Biology of Blood and Marrow Transplantation February 2007 (Vol. 13, Issue 2, Supplement, Pages 29-30)

6. Characteristics of the pediatric blood and marrow transplant advanced practice nurse. Y.J. Barnes, V.L. Fisher, E. Olson, PBMTC Nursing Discipline. Biology of Blood and Marrow Transplantation February 2007 (Vol. 13, Issue 2, Supplement, Page 58)

7. Job satisfaction among advanced practice nurses within the Pediatric Blood and Marrow Transplant Consortium. B. Browning, K. Thormann, K. Coyne, T. Halverson. The Pediatric Blood and Marrow Transplant Consortium Nursing Discipline. Biology of Blood and Marrow Transplantation February 2007 (Vol. 13, Issue 2, Supplement, Pages 59-60)

8. Nutritional support: A survey of Pediatric Blood and Marrow Transplant Consortium institutions. E.A. Olson, V.L. Fisher, Y.J. Barnes, M.A. Skeens, D. Niess. Biology of Blood and Marrow Transplantation February 2007 (Vol. 13, Issue 2, Supplement, Page 64)